Danny Huntington is a shareholder whose practice includes all phases of IP law, including litigation, US and foreign prosecution, licensing and general client counselling. When the US Patent and Trademark Office (USPTO) started declaring patent interferences involving biotechnology, Mr Huntington was one of the few attorneys knowledgeable in both interferences and biotechnology, and he soon found himself spending most of his time working in this field. His expertise led him to handle interferences involving other technologies and he has now handled more than 200 interferences. Mr Huntington is a member of the American Bar Association (ABA), the Federal Circuit Bar Association (FCBA), the American Intellectual Property Law Association (AIPLA) and its Patent Trial and Appeal Board (PTAB) Trial Committee, and the Intellectual Property Owners Association. He is also a member of the Fédération Internationale des Conseils en Propriété Industrielle (FICPI), of which he is a president of honour and a member of the Biotechnology Committee.